ACE Inhibitors, Angiotensin II Type-I Receptor Blockers and Severity of COVID-19
Clinical trial NCT04318418 · COMPLETED
Trial details
- NCT number
- NCT04318418
- Sponsor
- Neuromed IRCCS
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-03-23
- Primary completion
- 2020-05-10
- Enrollment
- 3400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.